Evaluation of Inhibitory Chimeric Antigen Receptor (ICARs) targeted against ErbB1 to overcome on-target off-tumour toxicity mediated by ErbB2 targeted CAR T-cells
Keyword(s): CAR T-cells, HER2, immunotherapy
Year: Legacy
Interested in this project?
If you would like to learn more about this project or explore a potential collaboration with the research team,
please contact us (The project title will be quoted automatically). We will forward your enquiry to the project lead to explore potential
opportunities for collaboration.
